-

JAMA Sub-Journal丨Breast Cancer Incidence Following False-Positive Mammogram Results
Mammography is the only imaging method proven to detect breast cancer early and reduce patient mortality; however, traditional mammography often yields false-positive results, and the long-term outcomes of these false positives remain unclear. Recently, a Swedish study involving 497,343 women found that the risk of breast cancer following a false-positive mammogram varies based on personal…
-

Leading Experts Discuss Current and Future Immunotherapy for TNBC, Guiding Precision Treatment Development丨2024 Breast Cancer Summer Forum·
On July 27-28, 2024, the “2024 Breast Cancer Summer Forum·Northern Salon” was grandly held at the Shougang Park in Beijing. The conference adhered to the concept of “learning, absorbing, innovating, and improving” and embraced the tradition of “All directions, Throughout time and across the world, Across all seasons, People of all ages and genders” offering…
-

Dr. Fu Fu Zheng: New Advances in Prostate Cancer Research at the 2024 ASCO Meeting 🌟 | Real-World Exploration and AI Applications in Prostate Cancer Pathology
Prostate cancer is a common malignant tumor of the reproductive system, particularly affecting elderly men. Screening high-risk populations and tailoring treatment plans based on patient characteristics are crucial for improving cure rates and enhancing quality of life. Recently, the 2024 ASCO Annual Meeting unveiled numerous advancements in the treatment of prostate cancer. “Oncology Frontier” invited…
-

Dr. Fu Fu Zheng: New Advances in Prostate Cancer Research at the 2024 ASCO Meeting (Real-World Exploration and Learning from Others)
Prostate cancer is a common malignant tumor of the reproductive system, particularly affecting elderly men. Screening high-risk populations and tailoring treatment plans based on patient characteristics are crucial for improving cure rates and enhancing quality of life. Recently, the 2024 ASCO Annual Meeting unveiled numerous advancements in the treatment of prostate cancer. “Oncology Frontier” invited…
-

2024 COMB丨Dr. Fei Ma: Metronomic Chemotherapy Combined with Immunotherapy Opens a New Chapter in Breast Cancer Research
In the field of breast cancer treatment, innovative therapies are emerging constantly, yet many issues still urgently need to be addressed. Recently, Academician Binghe Xu and Dr. Fei Ma from the Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College published an article in Nature Medicine titled “Metronomic chemotherapy plus anti-PD-1…
-

Dr. Fu Fu Zheng: New Advances in Prostate Cancer Research at the 2024 ASCO Meeting (Real-World Exploration and Learning from Others)
Prostate cancer is a common malignant tumor of the reproductive system, particularly affecting elderly men. Screening high-risk populations and tailoring treatment plans based on patient characteristics are crucial for improving cure rates and enhancing quality of life. Recently, the 2024 ASCO Annual Meeting unveiled numerous advancements in the treatment of prostate cancer. “Oncology Frontier” invited…
-

2024 COMB丨Dr. Tao Sun: Progress in HER2+ EBC Treatment—De-escalation Therapy and the Prospects of ctDNA Application
In recent years, the field of breast cancer treatment has seen a series of innovative research advancements, particularly in the treatment of HER2+ early breast cancer (EBC). Strategies such as “de-escalation,” “chemotherapy-free,” and “precision treatment” have become hot topics. At the 7th Precision Diagnosis and Treatment of Tumors and the 10th Individualized Treatment of Breast…
